Profile data is unavailable for this security.
About the company
Ascendis Pharma A/S is a Denmark-based company that manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The Company operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).
- Revenue in USD (TTM)342.91m
- Net income in USD-446.66m
- Incorporated2006
- Employees879.00
- LocationAscendis Pharma A/STuborg Boulevard 12HELLERUP 2900DenmarkDNK
- Phone+45 70222244
- Websitehttps://ascendispharma.dk/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Crinetics Pharmaceuticals Inc | 1.04m | -277.91m | 5.09bn | 290.00 | -- | 5.53 | -- | 4,902.86 | -3.72 | -3.72 | 0.0139 | 10.30 | 0.0013 | -- | 0.1222 | 3,582.76 | -34.61 | -42.53 | -36.80 | -45.36 | -- | -- | -26,298.27 | -5,446.39 | -- | -- | 0.00 | -- | -15.28 | 10.57 | -30.88 | -- | 34.65 | -- |
| Krystal Biotech Inc | 241.52m | 52.37m | 5.24bn | 229.00 | 103.14 | 5.92 | 88.24 | 21.71 | 1.77 | 1.77 | 8.21 | 30.80 | 0.2725 | 1.51 | 4.53 | 1,054,664.00 | 5.91 | -11.50 | 6.33 | -12.01 | 92.55 | -- | 21.68 | -492.85 | 7.76 | -- | 0.00 | -- | -- | -- | 107.81 | -- | 39.49 | -- |
| Ionis Pharmaceuticals Inc | 803.07m | -358.81m | 5.36bn | 927.00 | -- | 8.09 | -- | 6.67 | -2.45 | -2.45 | 5.50 | 4.20 | 0.267 | 0.3864 | 10.02 | 866,306.40 | -11.93 | -6.30 | -13.52 | -7.44 | 98.70 | 98.75 | -44.68 | -21.23 | 8.82 | -- | 0.6587 | -- | 34.10 | 5.60 | -35.80 | -- | 11.83 | -- |
| TG Therapeutics Inc | 264.79m | -14.36m | 5.38bn | 319.00 | -- | 28.01 | -- | 20.31 | -0.1067 | -0.1067 | 1.74 | 1.23 | 0.5775 | 0.5234 | 3.42 | 1,002,992.00 | -3.13 | -62.87 | -3.91 | -80.06 | 88.32 | -- | -5.42 | -405.03 | 3.91 | 0.2097 | 0.5596 | -- | 8,290.02 | 333.86 | 106.39 | -- | -- | -- |
| Cytokinetics, Inc. | 3.22m | -576.40m | 5.63bn | 423.00 | -- | -- | -- | 1,747.67 | -5.39 | -5.39 | 0.0301 | -0.118 | 0.003 | -- | 2.35 | 7,609.93 | -52.96 | -43.14 | -57.95 | -47.22 | -- | -- | -17,906.24 | -540.47 | -- | -14.27 | 1.02 | -- | -92.04 | -24.89 | -35.30 | -- | 9.76 | -- |
| Viking Therapeutics Inc | 0.00 | -99.15m | 5.75bn | 33.00 | -- | 6.31 | -- | -- | -0.937 | -0.937 | 0.00 | 8.18 | 0.00 | -- | -- | 0.00 | -15.02 | -21.91 | -15.47 | -23.04 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -24.73 | -- | -- | -- |
| Nuvalent Inc | 0.00 | -224.29m | 6.05bn | 127.00 | -- | 5.87 | -- | -- | -3.48 | -3.48 | 0.00 | 15.81 | 0.00 | -- | -- | 0.00 | -27.79 | -- | -29.25 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -54.20 | -- | -- | -- |
| Blueprint Medicines Corp | 434.41m | -128.05m | 6.14bn | 638.00 | -- | 19.58 | -- | 14.13 | -2.11 | -2.11 | 6.92 | 4.93 | 0.3769 | 0.8954 | 8.11 | 663,227.50 | -11.11 | -29.92 | -13.84 | -34.06 | 97.01 | -- | -29.48 | -116.65 | 3.27 | -10.80 | 0.5525 | -- | 22.22 | 41.14 | 9.06 | -- | 4.85 | -- |
| Madrigal Pharmaceuticals Inc | 76.81m | -518.67m | 7.18bn | 376.00 | -- | 9.24 | -- | 93.48 | -25.07 | -25.07 | 3.71 | 35.64 | 0.1172 | -- | -- | 204,289.90 | -79.11 | -62.09 | -100.35 | -74.81 | 96.37 | -- | -675.24 | -- | 5.93 | -- | 0.1309 | -- | -- | -- | -26.50 | -- | 132.01 | -- |
| Legend Biotech Corp (ADR) | 520.18m | -348.13m | 7.33bn | 2.40k | -- | 6.53 | -- | 14.08 | -1.91 | -1.91 | 2.85 | 6.08 | 0.291 | 9.29 | 1,434.99 | 288,990.60 | -19.47 | -37.71 | -22.25 | -47.19 | 62.88 | -- | -66.92 | -286.51 | 4.90 | -- | 0.237 | -- | 143.70 | 42.15 | -16.11 | -- | 1.57 | -- |
| Ascendis Pharma A/S (ADR) | 342.91m | -446.66m | 7.44bn | 879.00 | -- | -- | -- | 21.69 | -7.82 | -7.82 | 6.01 | -1.68 | 0.3329 | 0.2186 | 10.93 | 390,117.10 | -43.36 | -47.35 | -93.14 | -53.29 | 84.82 | -- | -130.26 | -602.66 | 0.8448 | -3.12 | 1.14 | -- | 421.20 | 90.68 | 17.45 | -- | -1.61 | -- |
| Tempus AI Inc | 640.44m | -800.71m | 8.26bn | 2.30k | -- | 151.72 | -- | 12.90 | -8.29 | -8.29 | 4.44 | 0.3459 | -- | -- | -- | -- | -- | -- | -- | -- | 53.18 | -- | -116.06 | -- | 2.55 | -14.95 | 0.891 | -- | 65.85 | -- | 20.35 | -- | -- | -- |
| Revolution Medicines Inc | 742.00k | -567.06m | 9.55bn | 490.00 | -- | 6.08 | -- | 12,872.64 | -3.59 | -3.59 | 0.0047 | 9.34 | 0.0005 | -- | 4.80 | 1,962.96 | -41.28 | -29.76 | -44.46 | -32.59 | -- | -- | -76,423.31 | -606.93 | -- | -- | 0.00 | -- | -67.27 | -10.50 | -75.46 | -- | 38.82 | -- |
| Exact Sciences Corp | 2.69bn | -214.04m | 9.82bn | 6.50k | -- | 3.06 | 5,387.82 | 3.65 | -1.17 | -1.17 | 14.70 | 17.35 | 0.4089 | 5.40 | 11.60 | 414,204.30 | -3.25 | -9.71 | -3.58 | -10.60 | 72.96 | 74.10 | -7.95 | -28.21 | 1.93 | -- | 0.4459 | -- | 19.93 | 40.63 | 67.26 | -- | -3.71 | -- |
| Charles River Lbrtrs ntrntl Inc | 4.06bn | 413.08m | 9.93bn | 20.00k | 24.24 | 2.63 | 12.93 | 2.45 | 8.01 | 8.01 | 78.63 | 73.97 | 0.5203 | 8.27 | 5.23 | 203,045.80 | 5.48 | 6.46 | 6.33 | 7.62 | 35.93 | 36.99 | 10.54 | 11.58 | 1.14 | 4.96 | 0.3784 | 0.00 | 3.86 | 12.75 | -2.39 | 16.69 | 17.86 | -- |
Data as of Nov 21 2024. Currency figures normalised to Ascendis Pharma A/S's reporting currency: US Dollar USD
70.77%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| RA Capital Management LPas of 30 Sep 2024 | 9.71m | 16.83% |
| Westfield Capital Management Co. LPas of 30 Sep 2024 | 5.13m | 8.90% |
| Avoro Capital Advisor LLCas of 30 Sep 2024 | 4.99m | 8.65% |
| Fidelity Management & Research Co. LLCas of 30 Sep 2024 | 4.55m | 7.89% |
| Artisan Partners LPas of 30 Sep 2024 | 4.41m | 7.64% |
| Janus Henderson Investors US LLCas of 30 Sep 2024 | 4.18m | 7.24% |
| T. Rowe Price Associates, Inc. (IM)as of 30 Sep 2024 | 2.12m | 3.68% |
| Capital Research & Management Co. (International Investors)as of 30 Sep 2024 | 2.11m | 3.66% |
| Massachusetts Financial Services Co.as of 30 Sep 2024 | 1.87m | 3.24% |
| T. Rowe Price Investment Management, Inc.as of 30 Sep 2024 | 1.77m | 3.06% |
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
